A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World Setting
Clinical trial NCT03160040 · COMPLETED
Trial details
- NCT number
- NCT03160040
- Sponsor
- Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-10-11
- Primary completion
- 2018-05-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.